HEIDELBERG UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1386-01-01

Employees: -

Market Cap: -

Website: https://www.uni-heidelberg.de/

Clinical Trials

Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Not Applicable

Completed

Conditions: Breast Neoplasms

Interventions: Device: Vacuum-Assisted Biopsy

First Posted Date: 2016-10-28

Last Posted Date: 2020-03-25

Lead Sponsor: Heidelberg University

Target Recruit Count: 452

Registration Number: NCT02948764

Locations: 🇩🇪
University Breast Unit, Department of Gynecology, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany

EBUS-TBNA vs Flex 19G EBUS-TBNA

Not Applicable

Conditions: Lymphadenopathy
Lung Cancer
Sarcoidosis
Lymphoma

Interventions: Device: 21G EBUS-TBNA needle
Device: Flexible 19G EBUS-TBNA needle

First Posted Date: 2016-09-27

Last Posted Date: 2017-02-07

Lead Sponsor: Heidelberg University

Target Recruit Count: 250

Registration Number: NCT02916459

Locations: 🇩🇪
Department of Pneumology and Critical Care medicine, Heidelberg, BW, Germany

Methylene Blue Against Falciparum Malaria in Burkina Faso

Phase 2

Completed

Conditions: Malaria, Falciparum

Interventions: Drug: Primaquine
Drug: Methylene Blue

First Posted Date: 2016-08-01

Last Posted Date: 2020-03-25

Lead Sponsor: Heidelberg University

Target Recruit Count: 100

Registration Number: NCT02851108

Locations: 🇧🇫
CRSN, Nouna, Burkina Faso

Differentiated Resistance Training of the Paravertebral Muscles in Patients With Unstable Spinal Bone Metastasis Under Concomitant Radiotherapy

Phase 2

Conditions: Vertebral Bony Metastases

Interventions: Other: Isometric resistance training

First Posted Date: 2016-07-28

Last Posted Date: 2016-07-28

Lead Sponsor: Heidelberg University

Target Recruit Count: 60

Registration Number: NCT02847754

Locations: 🇩🇪
Dept of Radiation Oncology, University of Heidelberg, Germany, Heidelberg, Germany

Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases

Phase 2

Conditions: Vertebral Bony Metastases

Interventions: Radiation: A
Radiation: D
Radiation: B
Radiation: C

First Posted Date: 2016-07-14

Last Posted Date: 2016-07-14

Lead Sponsor: Heidelberg University

Target Recruit Count: 120

Registration Number: NCT02832765

Locations: 🇩🇪
Dept of Radiation Oncology, University of Heidelberg, Germany, Heidelberg, Germany

Image-guided and Intensity-modulated Radiotherapy Versus External Beam Radiotherapy for Patients With Spine Metastases

Phase 2

Conditions: Vertebral Bony Metastases

Interventions: Radiation: fractionated RT
Radiation: IMRT

First Posted Date: 2016-07-14

Last Posted Date: 2016-07-14

Lead Sponsor: Heidelberg University

Target Recruit Count: 60

Registration Number: NCT02832830

Locations: 🇩🇪
Dept of Radiation Oncology, University of Heidelberg, Germany, Heidelberg, Germany

Anesthetic Depth Effects Upon Immune Competent Cells

Not Applicable

Completed

Conditions: Anesthesia
Inert Gas Narcosis
Immunotoxicity

Interventions: Drug: Low dose propofol, fentanyl and sevoflurane
Drug: High dose propofol, fentanyl and sevoflurane

First Posted Date: 2016-06-09

Last Posted Date: 2022-05-24

Lead Sponsor: Heidelberg University

Target Recruit Count: 16

Registration Number: NCT02794896

Locations: 🇩🇪
University Medicine of Mannheim, Dept. Anesthesiology and Critical Care Medicine, Mannheim, Germany

Proof of Concept of Adapted PD in Children (PC-AAPD)

Not Applicable

Completed

Conditions: Primary Study Outcome: Sodium Clearance in Dialysis
Solute Removal
Ultrafiltration

Interventions: Other: Adapted double mini PET
Other: Standard double mini PET

First Posted Date: 2016-04-22

Last Posted Date: 2018-05-08

Lead Sponsor: Heidelberg University

Target Recruit Count: 15

Registration Number: NCT02748733

Locations: 🇩🇪
Center for Pediatric and Adolescent Medicine, Heidelberg, BW, Germany

A Clinical Trial on a Group Treatment for Distressed Caregivers of Cancer Patients

Phase 3

Withdrawn

Conditions: Distress in Caregivers of Cancer Patients

Interventions: Behavioral: Individual treatment as usual
Behavioral: Tailored group intervention (PREPARE)

First Posted Date: 2016-04-15

Last Posted Date: 2016-10-26

Lead Sponsor: Heidelberg University

Registration Number: NCT02739243

Methylene Blue Against Vivax Malaria in Ethiopia

Phase 2

Withdrawn

Conditions: Vivax Malaria

Interventions: Drug: Artemeter-Lumefantrine (combination therapy)
Drug: Artemeter-Lumefantrine and MB (combination therapy)
Drug: Artemeter-Lumefantrine and Primaquine (combination therapy)

First Posted Date: 2016-03-02

Last Posted Date: 2020-03-25

Lead Sponsor: Heidelberg University

Registration Number: NCT02696928

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy